FunPep Company Limited (4881.T)
JPY 101.0
(-0.98%)
JPY 101.0
(-0.98%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 530 Thousand JPY | -50.33% |
| 2022 | 1.06 Million JPY | -99.16% |
| 2021 | 126.86 Million JPY | 4171.68% |
| 2020 | 2.97 Million JPY | -99.01% |
| 2019 | 301.41 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 414 Thousand JPY | 0.0% |
| 2024 Q2 | 116 Thousand JPY | -71.98% |
| 2023 Q2 | 262 Thousand JPY | -2.24% |
| 2023 Q4 | - JPY | 0.0% |
| 2023 Q1 | 268 Thousand JPY | 1.9% |
| 2023 FY | 530 Thousand JPY | -50.33% |
| 2023 Q3 | - JPY | -100.0% |
| 2022 Q3 | 184 Thousand JPY | 0.0% |
| 2022 FY | 1.06 Million JPY | -99.16% |
| 2022 Q4 | 263 Thousand JPY | 42.93% |
| 2021 FY | 126.86 Million JPY | 4171.68% |
| 2020 FY | 2.97 Million JPY | -99.01% |
| 2019 FY | 301.41 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 99.989% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | 99.531% |
| GNI Group Ltd. | 26.01 Billion JPY | 99.998% |
| Linical Co., Ltd. | 12.3 Billion JPY | 99.996% |
| Trans Genic Inc. | 13.08 Billion JPY | 99.996% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 99.92% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 99.99% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 99.966% |
| AnGes, Inc. | 152.98 Million JPY | 99.654% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 99.913% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 99.996% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 99.935% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | 99.609% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 99.967% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | 99.876% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 99.972% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 99.922% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 99.978% |
| PeptiDream Inc. | 28.71 Billion JPY | 99.998% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | 99.159% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | 99.562% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -636.111% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | 98.671% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 99.988% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 99.235% |
| Stella Pharma Corporation | 269.49 Million JPY | 99.803% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | 99.833% |
| Cuorips Inc. | 23.1 Million JPY | 97.706% |
| K Pharma,Inc. | 1 Billion JPY | 99.947% |
| Takara Bio Inc. | 43.5 Billion JPY | 99.999% |
| ReproCELL Incorporated | 2.42 Billion JPY | 99.978% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 99.969% |
| StemCell Institute Inc. | 2.48 Billion JPY | 99.979% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 99.979% |
| CellSeed Inc. | 190.13 Million JPY | 99.721% |